Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates

We compared ceftazidime-avibactam, ceftolozane-tazobactam, ceftazidime, cefepime, and piperacillin-tazobactam MICs for 38 meropenem-resistant Pseudomonas aeruginosa isolates. No isolates harbored carbapenemases; 74% were oprD mutants. Ceftazidime-avibactam and ceftolozane-tazobactam were active agai...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Buehrle, Deanna J., Shields, Ryan K., Chen, Liang, Hao, Binghua, Press, Ellen G., Alkrouk, Ammar, Potoski, Brian A., Kreiswirth, Barry N., Clancy, Cornelius J., Nguyen, M. Hong
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Susceptibility
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862525/
https://ncbi.nlm.nih.gov/pubmed/26976862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02969-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires